Correlation of Inflammatory Cytokines and Uric Acid Levels in Coronary Artery Disease with and Without Type 2 Diabetes Mellitus

Overview

Journal Bioinformation

Specialty Biology

Date 2023 Jun 16

PMID 37323554

Authors

D Selvakumar

C K Vijayasamundeeswari

Sandip Sendhav

Gnanadesigan Ekambaram

Affiliations

Soon will be listed here.

Abstract

Serum levels of inflammatory cytokines such as IL-6, high-sensitivity C-reactive protein as well as uric acids have been considered as predictors of severe outcomes in patients with coronary artery disease (CAD) associated with hypertension (HTN) and Type 2 Diabetes Mellitus (T2DM). Anthropometric parameters were recorded and measured the levels of major risk factors in 80 patients with hypertension, coronary artery disease with and without Type 2 diabetes mellitus and 40 healthy controls were included. Comparison were performed by classifying the study subjects into 3 groups namely- Group I: Controls (n=40); Group II: HTN, CAD without T2DM(n=40); and Group III: HTN,CAD with T2DM(n=40).The values of BMI, weight, SBP, DBP were greater in patients with T2DM CAD group when compared to without diabetes group. Data shows that there is a positive correlation between IL-6, hs-CRP and uric acid concentrations and are statistically significant. The evaluated high levels of inflammatory cytokines and uric acids in hypertensive CAD patients with diabetes might be helpful in the diagnosis of patients at greater risk.

References

Todd Miller M, Lavie C, White C . Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr. 2008; 3(3):162-7. DOI: 10.1111/j.1559-4572.2008.00004.x. View

Caselli C, de Graaf M, Lorenzoni V, Rovai D, Marinelli M, Del Ry S . HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain. Atherosclerosis. 2015; 241(1):55-61. DOI: 10.1016/j.atherosclerosis.2015.04.811. View

Shirai T, Nazarewicz R, Wallis B, Yanes R, Watanabe R, Hilhorst M . The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med. 2016; 213(3):337-54. PMC: 4813677. DOI: 10.1084/jem.20150900. View

Chae C, Lee R, Rifai N, Ridker P . Blood pressure and inflammation in apparently healthy men. Hypertension. 2001; 38(3):399-403. DOI: 10.1161/01.hyp.38.3.399. View

Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3):433-8. DOI: 10.1161/01.CIR.0000111245.75752.C6. View

Wong L, Leung R, Ong K, Cheung B . Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension. J Hum Hypertens. 2007; 21(11):875-82. DOI: 10.1038/sj.jhh.1002233. View

Ridker P . Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 2003; 108(12):e81-5. DOI: 10.1161/01.CIR.0000093381.57779.67. View

Leyva F, Anker S, Godsland I, Teixeira M, Hellewell P, Kox W . Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J. 1999; 19(12):1814-22. DOI: 10.1053/euhj.1998.1188. View

Kang D, Park S, Lee I, Johnson R . Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005; 16(12):3553-62. DOI: 10.1681/ASN.2005050572. View

10.

Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T . High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care. 2006; 29(2):329-33. DOI: 10.2337/diacare.29.02.06.dc05-1700. View

11.

Bigazzi R, Bianchi S, Buoncristiani E, Campese V . Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up. Nutr Metab Cardiovasc Dis. 2007; 18(4):314-9. DOI: 10.1016/j.numecd.2006.11.001. View

12.

Menuet R, Lavie C, Milani R . Importance and management of dyslipidemia in the metabolic syndrome. Am J Med Sci. 2005; 330(6):295-302. DOI: 10.1097/00000441-200512000-00007. View

13.

Wannamethee S, Whincup P, Rumley A, Lowe G . Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost. 2007; 5(8):1637-43. DOI: 10.1111/j.1538-7836.2007.02643.x. View

14.

Bermudez E, Rifai N, Buring J, Manson J, Ridker P . Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002; 22(10):1668-73. DOI: 10.1161/01.atv.0000029781.31325.66. View

15.

Wei J, Xu H, Davies J, Hemmings G . Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci. 1992; 51(25):1953-6. DOI: 10.1016/0024-3205(92)90112-3. View

16.

Anan F, Takahashi N, Nakagawa M, Ooie T, Saikawa T, Yoshimatsu H . High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism. 2005; 54(4):552-8. DOI: 10.1016/j.metabol.2004.11.012. View

17.

Jandeleit-Dahm K, Gray S . Insulin and cardiovascular disease: biomarker or association?. Diabetologia. 2012; 55(12):3145-51. DOI: 10.1007/s00125-012-2729-4. View

18.

Calabro P, Golia E, Yeh E . Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches. Curr Pharm Biotechnol. 2011; 13(1):4-16. DOI: 10.2174/138920112798868764. View

19.

Sharma S, Garg S, Veerwal A, Dwivedi S . hs-CRP and oxidative stress in young CAD patients: A pilot study. Indian J Clin Biochem. 2012; 23(4):334-6. PMC: 3453131. DOI: 10.1007/s12291-008-0073-8. View

20.

Nevado J, Peiro C, Vallejo S, El-Assar M, Lafuente N, Matesanz N . Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells. Br J Pharmacol. 2005; 146(2):268-79. PMC: 1576262. DOI: 10.1038/sj.bjp.0706309. View